학술논문
폐암의 방사선치료 결과
이용수 11
- 영문명
- Result of Radiation Therapy for the Lung Cancer
- 발행기관
- 대한방사선종양학회
- 저자명
- 김주영(Joo-Young Kim) 최명선(Myung-Sun Choi) 서원혁(Won-Hyck Suh)
- 간행물 정보
- 『대한방사선종양학회지』제7권 제2호, 213~225쪽, 전체 13쪽
- 주제분류
- 의약학 > 종양학
- 파일형태
- 발행일자
- 1989.12.30
4,360원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.
국문 초록
영문 초록
An analysis has been made of two hundred seven patients who were treated at the department of Radiation Oncology of Korea University Hospital for lung cancer from January 1981 through December 1986.
There were 137 patients of nonsmall cell carcinoma (137/207, 66%), 26 patients of small cell carcinoma (26/207, 12,5%) and 44 patients of unproven histology. By aims of treatment, there were 104 patients (104/207, 50%) treated for cure, 89 patients (89/207, 42.9%) or palliation and 14 patients treated postoperatively. In 22 out of 207 patients, chemotherapy was done with radiotherapy, 12 of which were patients with small cell carcinoma.
Stage II patients were 49 (49/207, 23.6%). stage III patients were 157 (157/207, 75.8%) and one patient had an occult cancer.
The tumor was initially measured by CAT scan and chest X-rays in the 165 (165/207, 79.7%) patients. among which 117 patients had tumor diameter more than 5cm and 48 patients less than 5cm.
Radiation therapy was given with Cobalt 60 teletherapy unit and the treatment volume encompassed primary tumor and the mediastinum. For curative aim, daily tumor dose of 180 cGy was given up to the range of 5,400~6,120 cGy/30~34 F/6~7 week period and for palliative aim, daily tumor dose of 300 cGy was given up to the range of 3.600~4,500 cGy/12~15 F/2~3 week period.
Postoperatively, mediastinum was treated for total dose of 5,040 cGy 28 F/5.5week period.
123 patients (123/207, 59%) were followed up after completion of radiotherapy for 14 months to 7 years.
Local tumor response to the irradiation was measured by chest X-ray taken at one month follow up and was evaluated for response rate, if they were regressed more than 50% or less than 50% of the initial tumor size.
The treatment results were as follows:
1. The median survival time was 8.5 months and survival rates for 1 year, 2 year and 5 year was 25%, 3.5% and 1% of nonsmall cell lung ca of 74 evaluable patients.
2. More than 50% of local tumor response rate was obtained in about hal of overall cases: 90.5% for small cell ca, 50% for squamous cell ca, 25% for adenoca and 57%, for large cell ca.
3, Response rate more than 50% was seen in the 50% of the patient group with tumor diameter more than 5 cm and in the 55% of those with tumor diameter less than 5cm.
4. By total raidation dose given, patient group which was given 5,400~6,120 cGy equivalent dose or higher showed tumor response rate more than 50% in 53% of the patients, whereas the group with dose less than 5,400 cGy equivalent, in 25% of the patients.
5. Survival rate for 6 month, 1 year and 2 year was compared between the group of local tumor response rate more than 50% vs. group with response rate less than 50%; 74% vs. 43%, 33% vs. 23%, 10% vs. 1% respectively.
6. Local failure was seen in 21%(44/207) of the patients, which occured mostly within 15 months after completion of radiation therapy. Distant metastases were seen in 49. 7%(103/207) of he patients, of which 43 cases were found before initiation of radiotherapy.
The most common metastatic sites were bone and brain.
In this sutdy, 1 year, 2 year and 5 year survival rates were somewhat poor compared to the other studies. It mainly seems to be due to the poor general status of he patients and the far-advanced stage of the disease.
In nonsmall cell cancer patients who had limited local disease and had small primary tumor size, we observed better local response. In addition, dose higher than 6,000 cGy group showed better tumor control than lower dose group. Survival rate was better for the local control group.
For imporvement of local control of the lung cancer and hence, the survival of the patients with lung cancer, proper radical radiotherapy with high dose for localized disease is needed. New modality of treatement, such as high LET beam in radiation therapy of drugs for the advanced disease as well as early diagnosis is also needed.
목차
해당간행물 수록 논문
- 코발트-60 감마선의 전자 오염에 관한 연구
- 방사선조사와 온열요법이 백서신에 미치는 조직변화에 관한 실험적 연구
- 단순 흉부 X-선 사진상 폐암 소견에 대한 방사선 치료의 효과
- The Result of Combined Modelity Treatment for Limited Stage Small Cell Lung Cancer
- 자궁경부암에서 대동맥 임파절 전이의 치료
- 악성 횡문근 육종의 방사선 치료
- 폐암의 방사선치료 결과
- Dose-Rate Effects Generated from Repair and Regeneration
- Lethal Effects of Radiation and Platinum Analogues on Multicellular Spheroids of HeLa Cells
- Combined Radiotherapy and Hyperthermia for Nonresectable Hepatocellular Carcinoma
- External Beam Radiotherapy for Primary Spinal cord Tumors
- A Study on Dose Distribution around Fletcher-Suit Colpostat Containing Cs-137 Source by a Computer
- Variation in Depth Dose Data between Open and Wedge Fields for 6 MV X-Rays
- Effect of Prophylactic Cranial Irradiation in Acute Lymphoblastic Leukemia in Children
- 뇌하수체 선종의 방사선 치료 결과
- 선형가속기의 6MV X선에 대한 소형조사면의 선량측정
- Radiotherapy Result of Brain Stem Tumors
- 고선량 Ir-192 선원 교정기의 제작 및 특성
참고문헌
관련논문
의약학 > 종양학분야 BEST
- 방사선 치료에 내성이 유도된 두경부 편평세포암에 대한 종양살상 헤르페스 바이러스의 유전자 치료 효과
- 식도암에서 근치적 절제술 후 방사선치료의 역할
- 두경부암에서 면역회피 기전과 면역항암제 치료
의약학 > 종양학분야 NEW
- Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study
- Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neck
- Hypofractionated radiation therapy for head and neck cancers in the era of intensity-modulated radiation therapy
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!